BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 23750566)

  • 1. Is there any benefit in surgery for potentially malignant disorders of the oral cavity?
    Balasundaram I; Payne KF; Al-Hadad I; Alibhai M; Thomas S; Bhandari R
    J Oral Pathol Med; 2014 Apr; 43(4):239-44. PubMed ID: 23750566
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcomes of oral squamous cell carcinoma arising from oral epithelial dysplasia: rationale for monitoring premalignant oral lesions in a multidisciplinary clinic.
    Ho MW; Field EA; Field JK; Risk JM; Rajlawat BP; Rogers SN; Steele JC; Triantafyllou A; Woolgar JA; Lowe D; Shaw RJ
    Br J Oral Maxillofac Surg; 2013 Oct; 51(7):594-9. PubMed ID: 23601832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of cornulin, keratin 4, keratin 13 expression and grade of dysplasia for predicting malignant progression of oral leukoplakia.
    Schaaij-Visser TB; Bremmer JF; Braakhuis BJ; Heck AJ; Slijper M; van der Waal I; Brakenhoff RH
    Oral Oncol; 2010 Feb; 46(2):123-7. PubMed ID: 20036603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of ELF3 immunoexpression is useful for detecting oral squamous cell carcinoma but not for distinguishing between grades of epithelial dysplasia.
    AbdulMajeed AA; Dalley AJ; Farah CS
    Ann Diagn Pathol; 2013 Aug; 17(4):331-40. PubMed ID: 23643910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors predicting malignant transformation in oral potentially malignant disorders among patients accrued over a 10-year period in South East England.
    Warnakulasuriya S; Kovacevic T; Madden P; Coupland VH; Sperandio M; Odell E; Møller H
    J Oral Pathol Med; 2011 Oct; 40(9):677-83. PubMed ID: 21762430
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Potentially malignant disorders of the oral mucosa: terminology and classification].
    Ben Slama L
    Rev Stomatol Chir Maxillofac; 2010 Sep; 111(4):208-12. PubMed ID: 20739038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term treatment outcome of oral premalignant lesions.
    Holmstrup P; Vedtofte P; Reibel J; Stoltze K
    Oral Oncol; 2006 May; 42(5):461-74. PubMed ID: 16316774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Malignant transformation of oral epithelial dysplasia: a real-world evaluation of histopathologic grading.
    Dost F; Lê Cao K; Ford PJ; Ades C; Farah CS
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2014 Mar; 117(3):343-52. PubMed ID: 24388536
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management for premalignant lesions of the oral cavity.
    Panwar A; Lindau R; Wieland A
    Expert Rev Anticancer Ther; 2014 Mar; 14(3):349-57. PubMed ID: 24559323
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinicopathological characteristics of malignant transformation in 85 cases of oral leukoplakia].
    Gao Y; Guo ZL; Luo HY; Wang J
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2012 Jul; 47(7):410-3. PubMed ID: 22931571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictive value of dysplasia grading and DNA ploidy in malignant transformation of oral potentially malignant disorders.
    Sperandio M; Brown AL; Lock C; Morgan PR; Coupland VH; Madden PB; Warnakulasuriya S; Møller H; Odell EW
    Cancer Prev Res (Phila); 2013 Aug; 6(8):822-31. PubMed ID: 23761273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of a new binary system of grading oral epithelial dysplasia for prediction of malignant transformation.
    Kujan O; Oliver RJ; Khattab A; Roberts SA; Thakker N; Sloan P
    Oral Oncol; 2006 Nov; 42(10):987-93. PubMed ID: 16731030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histological grading of oral epithelial dysplasia: revisited.
    Warnakulasuriya S
    J Pathol; 2001 Jul; 194(3):294-7. PubMed ID: 11439360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Precancerous lesions of the buccal mucosa].
    Ben Slama L
    Rev Stomatol Chir Maxillofac; 2001 Apr; 102(2):77-108. PubMed ID: 11446145
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular markers in oral epithelial dysplasia: review.
    Pitiyage G; Tilakaratne WM; Tavassoli M; Warnakulasuriya S
    J Oral Pathol Med; 2009 Nov; 38(10):737-52. PubMed ID: 19903246
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potentially malignant disorders of the oral and oropharyngeal mucosa; present concepts of management.
    van der Waal I
    Oral Oncol; 2010 Jun; 46(6):423-5. PubMed ID: 20308005
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigation of p16(INK4a) as a prognostic biomarker in oral epithelial dysplasia.
    Nankivell P; Williams H; Webster K; Pearson D; High A; MacLennan K; Senguven B; McConkey C; Rabbitts P; Mehanna H
    J Oral Pathol Med; 2014 Apr; 43(4):245-9. PubMed ID: 24372672
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognosis of oral pre-malignant lesions: significance of clinical, histopathological, and molecular biological characteristics.
    Reibel J
    Crit Rev Oral Biol Med; 2003; 14(1):47-62. PubMed ID: 12764019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The relevance of EGFR overexpression for the prediction of the malignant transformation of oral leukoplakia.
    Ries J; Vairaktaris E; Agaimy A; Bechtold M; Gorecki P; Neukam FW; Nkenke E
    Oncol Rep; 2013 Sep; 30(3):1149-56. PubMed ID: 23784518
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of MAGE-A expression and grade of dysplasia for predicting malignant progression of oral leukoplakia.
    Ries J; Agaimy A; Vairaktaris E; Kwon Y; Neukam FW; Strassburg LH; Nkenke E
    Int J Oncol; 2012 Sep; 41(3):1085-93. PubMed ID: 22751922
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.